Scalper1 News
Some of the biggest drugmakers in the world are reporting earnings this week, and while their quarters are expected to be dampened by patent losses and foreign-exchange headwinds, each has a potential growth story in the works. On Tuesday, a trio of big U.S. pharmas are due to report. Pfizer (PFE) is expected to report a 14% drop from year-earlier earnings to 49 cents a share, according to Thomson Reuters’ poll of analysts. Sales are seen falling Scalper1 News
Scalper1 News